Axa
IDYA icon

Axa’s IDEAYA Biosciences IDYA Stock Holding History

Axa’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-324,543
Closed -$6.82M – 550
2025
Q2 		$6.82M Buy
324,543
+523
+0.2% +$10K 0.02% 490
2025
Q1 		$5.31M Buy
324,020
+74,318
+30% +$1.58M 0.02% 526
2024
Q4 		$6.42M Buy
249,702
+41,722
+20% +$1.18M 0.02% 478
2024
Q3 		$6.59M Sell
207,980
-35,504
-15% -$1.35M 0.02% 475
2024
Q2 		$8.55M Buy
243,484
+136
+0.1% +$5.39K 0.03% 412
2024
Q1 		$10.7M Buy
243,348
+68
+0% +$2.92K 0.03% 395
2023
Q4 		$8.66M Sell
243,280
-100,475
-29% -$3M 0.03% 425
2023
Q3 		$9.27M Sell
343,755
-1,206
-0.3% -$30.6K 0.03% 405
2023
Q2 		$8.11M Buy
344,961
+4,745
+1% +$97.6K 0.03% 451
2023
Q1 		$4.67M Sell
340,216
-753
-0.2% -$12.5K 0.02% 587
2022
Q4 		$6.2M Sell
340,969
-88,149
-21% -$1.48M 0.02% 535
2022
Q3 		$6.4M Buy
429,118
+1,870
+0.4% +$24.3K 0.03% 529
2022
Q2 		$5.9M Buy
427,248
+145,144
+51% +$1.61M 0.02% 539
2022
Q1 		$3.16M Buy
282,104
+2
+0% +$29 0.01% 758
2021
Q4 		$6.67M Buy
282,102
+3,369
+1% +$78.3K 0.02% 593
2021
Q3 		$7.11M Buy
278,733
+38,626
+16% +$902K 0.02% 588
2021
Q2 		$5.04M Buy
+240,107
New +$4.93M 0.01% 708

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Axa's IDYA Position: Q3 2025 in Review

Axa sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 324,543 shares — an estimated $6.82M sold.

Axa first reported a position in IDYA in Q2 2021 and held it in 17 quarters. The position peaked at $10.7M in Q1 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Axa reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Axa sold 324,543 IDEAYA Biosciences shares in Q3 2025, an estimated $6.82M.
  • Axa first reported a position in IDEAYA Biosciences in Q2 2021 and held it in 17 quarters.
  • Axa's IDEAYA Biosciences position peaked at $10.7M in Q1 2024.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.